Until recently there has been fairly general agreement that gonadotrophins are not detectable in the urine during childhood. Table I summarizes the results of previous investigators in this field. Of the early workers, only Catchpole and Greulich (1943) have, in serial determinations, detected gonadotrophins in young girls. More recently, studies performed on pools of urine have indicated that gonadotrophins are excreted as early as 3 to 5 years in boys (Knappe, Dorner, and Stahl, 1961) , and possibly in girls (Carletti and Kehyayan, 1962a, b) , though the latter workers used combined pools for boys and girls. Full experimental details have not been published to substantiate the claim of Minkina (1961) that gonadotrophin excretion in girls aged 1-3 years is very much higher than in girls at or near the menarche.
In 1960, Landau, Schwartz, and Soffer suggested that children's urine contained an inhibitor for gonadotrophins. They observed inhibition of the response when extracts of children's urine were combined with extracts of known gonadotrophic potency. A later report (Soffer, Futterweit, and Salvaneschi, 1961 ) substantiated these observations, particularly with regard to children under 6 years of age. Soffer, Salvaneschi, and Futterweit (1962) claimed to have detected a factor in all age-groups that inhibited the action of human chorionic gonadotrophin (HCG), but failed to inhibit the uterine response to oestrone.
In view of the paucity both of positive results in young children and of results in terms of standard reference preparations, it seemed of value to investigate again the excretion of gonadotrophins in childhood. This was an essential preliminary to assessing gonadotrophin excretion in pathological conditions.
The increase in uterine weight of the immature mouse is regarded as the most sensitive end-point for the routine bio-assay of total urinary gonadotrophins (Rosemberg, 1961) . Though methods commonly * Present address: National Chemical Research Lab., P.O. Box 395, Pretoria, South Africa. Requests for reprints should be sent to Dr. B. Clayton.
employed have involved multiple injections over a three-day period (Loraine and Brown, 1959) , it was thought that the use of a single injection method such as that of Claringbold and Lamond (1957) might afford a more sensitive assay because a threshold dose would not be subdivided into sub-threshold doses. Since Lamond and Claringbold (1958) failed to demonstrate synergism between various gonadotrophins in an assay depending on the early response of the uterus after a single injection, it is likely that such an assay will more accurately reflect the total gonadotrophin present (follicle stimulating hormone (FSH) and luteinizing hormone (LH)). Brown and Billewicz (1962) showed that if enough time were allowed for growth and differentiation of the ovary (as in the usual three-day assay), the same uterine response was achieved by a wide variation in the total dose of gonadotrophin, using different proportions of FSH and LH. Thus extracts containing unknown proportions of FSH and LH could not be reliably assayed in an assay allowing extensive differentiation of the ovary, except at very low levels when the uterine response to FSH and LH was similar. Taking these facts into account, a more sensitive method for the assay of total urinary gonadotrophins has been developed.
In addition, luteinizing hormone (LH) has been estimated in children's urine using the ovarian ascorbic acid depletion assay, as modified by Schmidt-Elmendorff and Loraine (1962) .
Material and Methods Hormones Used in Assays. These are listed below.
(1). Human menopausal gonadotrophin. International Reference Preparation (I.R.P.) (Bull. Wid Hlth Org., 1960) . (2). Human chorionic gonadotrophin (HCG). The preparation used was gonadotrophin LH (Paines and Byrne, Ltd.). (3). Human menopausal gonadotrophin (LAB-G). This preparation was extracted and purified from postmenopausal urine by the method of Loraine and Brown (1959) . It was assayed in terms of I.R.P. using the modification of the mouse uterus method as described in this paper, and the following data were oltained. Index of significance of slope b: g = 0 083 (i.e. significant). (4). Luteinizing hormone (NIH-LH-S-1).* Extraction Method. Extracts were prepared from complete 24-hour urine specimens (or multiples thereof) and from pooled random specimens of urine by the kaolin-acetone method of Albert (1956) Borth, Lunenfeld, and Menzi (1961) , but using the adjustments of pH as described by Loraine and Brown (1959) . Extracts were purified by salt-ethanol fractionation (stage 2, Albert, Kobi, Leiferman, and Derner, 1961) .
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For the assay of total urinary gonadotrophins and luteinizing hormone, the extracts were dissolved in 0 1 M borate buffer (pH 9) and 0 * 9 % NaCl respectively, so that each mouse or rat received 0 25 or 0-2 ml., respectively. 0 *1 M borate buffer: 100 ml. boric acid (6 * 18 g./l.) mixed with 42 -6 ml. sodium hydroxide (4 g. /1. Gaddum (1953 b) and Borth, Diczfalusy, and Heinrichs (1957) .
Genital and Secondary Sex Character Rating. TI was assessed according to Tanner (1955) , but for vario reasons it was not possible to do this in every child.
Bio-assay of Total Urinary Gonadotrophins Extracts were assayed by a modification of the mou uterus test of Klinefelter, Albright, and Griswold (1942 Each mouse received 0 1 i.u. HCG subcutaneously 0 1 ml. 0 9% NaCl; 24 hours later the standard extract was administered as a single injection, and t] mice were killed by decapitation 40 to 44 hours late The uteri were dissected out, placed in Bouin's fluid f 24 hours, cleaned, blotted dry, and weighed to the neare 1 mg. on a torsion balance.
The design of the assays is described in the sectioi relating to the clinical investigations performed, dos response curves for Standard being constructed usi total dosages of LAB-G of 0 39 to 1 * 34 mg./mouse.
Development of Method. (1). Determination ofthe time ofmaximum response aft a single injection of LAB-G: in three separate investig tions, a total of 68 mice were injected with 1 * 0 mg. LABand killed in groups of four at intervals between 10 and' hours after injection.
The uterine responses obtained are shown in LAB-G was injected into 2 groups of 8 mice. Group A ons received the total amount divided into 5 doses; 2 injecse-tions were given on both the first and second days, and one ng on the third day. The mice were killed 72 hours after the first injection. Group B received the total amount as a single injection, and the mice were killed 40 to 44 hours later. A control group of 5 mice, injected as in Group B, ter received saline only.
Ia-
The mean uterine weights (± standard errors of the -G means) were as follows. Group A: 4-7 ± 0 4 mg.; 70 Group B: 7-6 + 0 3 mg.; and saline controls: 4-4 + 04 mg. 1.
The uterine weights in Group B were significantly greater than those of Group A (p < 0 * 005). I (3). Determination of a satisfactory priming dose of HCG: mice, in groups of 5, were given single injections of HCG in doses of 0-10 to 1 0 i.u. per mouse; they were killed 40 to 44 hours later. The uterine weights are shown in Table 2 standard deviation. Table 4 , and recorded diagrammatically in Fig. 3 , in which the logarithm of the total dose of LAB-G is plotted against the percentage increase in uterine weight, the control uterine weight being taken as 100%.
It was concluded that maximum sensitivity and the steepest dose-response line at low doses was achieved by using a single injection of LAB-G following pretreatment with HCG. Schedule (a) has been used in all subsequent assays of total urinary gonadotrophin. and assayed against LAB-G using 10 mice per group and a (2 + 1) assay design.
No gonadotrophic activity was detected in the urine containing no added LAB-G. Recoveries of added LAB-G are shown in Table 5 .
Four samples of LAB-G, each of 10-0 mg., were purified by the salt-ethanol fractionation procedure, and assayed against LAB-G itself using 5 mice per group and a (2 + 1) assay design. Results are shown in Table 5 . In view of the number of steps involved and the errors inherent in the bio-assay, the recoveries were considered reasonably satisfactory. (9). Precision: a pool of 4 litres of urine from normal men was divided into 4 aliquots which were extracted and purified. Each extract was assayed against LAB-G using a (2 + 1) assay design and 10 mice per group. The results, shown in Table 6 , indicated satisfactory reproducibility.
The precision of the assay was satisfactory, Gaddum's A being < 0-2 except on two occasions. Fiducial limits for assays are given in the relevant sections on clinical application of the method. (10). Toxicity ofthe purified extract: no toxic effects were observed when purified extracts (equivalent to a 24-hour urine output) from children and adults were injected into individual mice. It was frequently possible to inject twice the equivalent of a 24-hour urine from a child into each mouse. (11). Sensitivity: over a period of two years, the mean control uterine weight of mice which received 0 1 i.u. HCG only, was consistently between 3 5 and 4 5 mg. Data with respect to three standard curves, selected at random from the results available, are shown in Table 7 .
Bio-assay of Luteinizing Hormone in Urine Luteinizing hormone in urine was assayed by the method of ovarian ascorbic acid depletion, as modified by Schmidt-Elmendorff and Loraine (1962) using NIH-LH as a reference preparation. Symmetrical four-point assays with two dose levels of standard (S) and unknown (U) respectively were used, the log dose interval being log553 (0 4771): 4 or 5 rats (8 or 10 ovaries) were used at each dose. 
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17-1 4-1 14-2 3-8 10-5 3-1 0-88 17-7 6-2 17-9 ±59 12-6 2-9 1-34 27-1 8-7 27-6±7-0 20-6±6- Clinical Investigations and Results Four-point Assays for Total Gonadotrophins on Urine from Normal Subjects. Assays using a (2 +-2) design and 5 mice per group were performed on extracts of urine from healthy subjects, both adults and children. All the assays were statistically valid and results are shown in Table 8 .
Excretion of Total Urinary Gonadotrophins in
Normal Men and Women. Pools of urine comprising 2 to 6 complete 24-hour collections from each subject were assayed for gonadotrophic activity using a 3 (standard) + I (unknown) design with 5 mice per group.
In 12 healthy men aged 18 to 40 years, total urinary gonadotrophins ranged from 3 * 8 to 18 * 1 mg. f.R.P./24 hr. with a mean of 7-7. Eight healthy women aged 18 to 35 years were studied, and 24-hour urine collections were made at random during the cycle and pooled for each subject, no attempt being made to follow changes during individual menstrual cycles. The mean excretion of total urinary gonadotrophins was 4 9 mg. f.R.P./24 hr. with a range of 2 -7 to 7 05.
Effect of Extracts from Urine of Children on Assay of Total Urinary Gonadotrophin. In order to determine whether children's urine extracted by the method described contained an inhibitor to gonadotrophic activity, extracts of urine were added to a standard amount of I -0 mg. LAB-G as shown in Table 9 , and the mixture was assayed according to the usual procedure.
The uterine weights obtained are shown in Table 9 . The extracts alone did not cause any increase in uterine weight. When combined with LAB-G they did not significantly alter the response to 1 -0 mg. LAB-G. None of the mice showed evidence of toxicity in this experiment. There was no evidence to suggest that an inhibitor was present in extracts prepared from children's urine by the method already described.
Total Urinary Gonadotrophin Excretion in Children Without Endocrinological Abnormalities. The majority of assays were of 4 (standard) + I (unknown) design, using 5 mice at each dose level for the standard and 3 to 5 for the unknown, depending on the amount of extract available. The limit of sensitivity for each assay varied according to the amount of extract injected and the sensitivity of the mice. If the largest dose of extract injected failed to cause a positive response, the result was recorded as 'undetectable activity and less than x mg. I.R.P./24 hr.', the value of x varying with the sizes of the responses to the standard and the amount of extract injected. No toxic effects were observed when purified extracts equivalent to a 24-hour urine collection were injected into each mouse. For(l) and (3) girls 7-9 yr. Assays were performed on urine from 46 boys and 58 girls aged 3 months to 15 years 8 months. The results are given in Tables 10 and 1 1, and are shown diagrammatically in Fig. 5 .
Measurable activity was obtained as early as 9 months in a boy and 1 year 10 months in a girl.
Serial determinations were made on 2-or 3-day pools of complete 24-hour urines, as follows. Urinary Excretion of Luteinizing Hormone by Children without Endocrinological Abnormalities. A series of assays was performed on pooled collections of urine from children of various age-groups. There were 6 to 8 children in each age-group, and the results are shown in Table 12 . Toxic reactions were produced with urine from the higher age-groups, both boys and girls, even though the amount of extract injected was generally equivalent to less than 24-hour urine. In the lower age-groups the toxic effect (if any) was much less marked, even though the amount of extract injected into each rat exceeded the equivalent of 24-hour urine.
Assays were also performed on individual pools of 24-hour urines obtained from 12 children: 4 assays were invalid because of significant deviation from parallelism and 2 assays showed no depletion of ovarian ascorbic acid at the highest dose injected. Results of valid assays are shown in Table 12 . 
Discussion
The immature mouse uterus has been used as a reliable and sensitive end-point for the bio-assay of total urinary gonadotrophins. The extract has been administered as a single injection following pretreatment of the mice with a sub-threshold dose of HCG.
From results published by other investigators (Borth et al., 1961) , it is clear that many strains of mice have a greater sensitivity to human menopausal gonadotrophin than the strain available for the present study, so that the method described could have even greater sensitivity.
The mechanism of potentiation with HCG remains obscure. The fact that simultaneous administration of HCG and LAB-G did not show any synergistic interaction raises the possibility that this phenomenon is only demonstrable when HCG is administered before an injection containing follicle-stimulating hormone. This aspect appears to have been overlooked in most studies on synergism because assays extending over several days have been used (Evans and Simpson, 1950) . The extraction and assay used in the present study gave reproducible results of reasonable accuracy. Recovery experiments showed results similar to those reported by Loraine and Brown (1959) and Heinrichs and Eulefeld (1960) . This type of recovery can be criticized (Albert, 1956 ), because it is not certain that gonadotrophin added to raw urine or extracts will behave in the same way as it did initially in the original urine. The four-point assays with extracts of urine from pre-adolescent children and adults showed satisfactory similarity of response with the laboratory standard LAB-G which was obtained from post-menopausal urine. The levels found in men and women were similar to those reported by other investigators who used similar extraction procedures (Apostolakis, 1961; Brown, 1959a, b; Loraine and Bell, 1963 tion in excretion as indicated by the serial determinations. Intermittent excretion was seen in M.M. aged I year and 10 months, and also in the postmenarchal subject studied (M.D., 12 years and 5 months). As with the boys, assays of total urinary gonadotrophin must be interpreted with these limitations in mind. In general, results for total The ovarian ascorbic acid depletion assay of urinary extracts containing low levels of LH presented considerable difficulties. The large amount of extract that had to be injected produced toxic effects and resulted in death of some of the animals. The rather flat slope of the dose-response curve usually resulted in an unsatisfactory index of precision and wide fiducial limits. This is in accord with the results published by Schmidt-Elmendorff and Loraine (1962) , though Bell, Mukerji, and Loraine (1964) have recently published a modification of the method overcoming all these difficulties.
In pooled urine from boys, measurable LH was found in all age-groups, the amount increasing with age. Similar results were seen in girls but the assay on the 0 to 6 year age-group was invalid. The results suggest that there may be a correlation between the onset of puberty and the excretion of LH, and this would be worth further investigation using the improved method of Bell et al. (1964) .
No evidence suggesting a gonadotrophin inhibitor in children's urine has been found. The method of extraction and purification used in the present study is different from that of Soffer et al. (1961 Soffer et al. ( , 1962 , and perhaps this explains the conflicting results.
The values, in terms of a reference preparation for gonadotrophin excretion in normal children, will enable the results found in pathological states, e.g. precocious puberty, to be better evaluated. Failure to demonstrate gonadotrophin in the urine of any particular child must be interpreted in the light of the findings in the normal child, and the other clinical and laboratory findings must be taken carefully into account. Summary The excretion of total urinary gonadotrophin was studied in endocrinologically normal boys and girls, and the results were expressed in terms of a standard reference preparation. Low amounts were frequently found in children's urine even before the age of puberty, the youngest boy being 9 months and girl 1 year and 10 months. The inability to detect gonadotrophin in any particular child must be interpreted with caution and in the light of the other clinical and laboratory findings. No CP44 m urinary gonadotrophic activity could be demonstrated with the method of extraction and purification used in this study. A method specific for luteinizing hormone was applied to pools of children's urine, and detectable amounts were present both before and after puberty. There was considerable variation in excretion among the few individuals studied separately.
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